The treatment only has a 50% success rate so far, but those who have received it have reportedly experienced no significant ...

He and his team at Kyoto University had reprogrammed adult mouse fibroblasts into so-called induced pluripotent stem cells (iPSCs) 1, opening the stem cell field to legions of eager scientists and ...

研究人员从 Singleton-Merten 综合征（SMS）患者血细胞中制备 iPSCs，为研究 SMS 提供工具，助力罕见病研究。 Singleton-Merten 综合征（SMS）是一种罕见的遗传疾病，与异常钙化和骨骼畸形有关。为探究这种疾病的潜在机制，研究人员从一名 SMS 患者的血细胞中生成了诱导 ...

The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

The authors have generated important resources such as a reference dataset of early primate development by utilizing single-cell transcriptomic technology together with induced pluripotent stem cells ...

CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the company’s new name ...

In a potentially major breakthrough for regenerative medicine, scientists at MIT have developed a way to convert skin cells ...

Only a few universities nationwide, including the University of Southern California and Harvard, offer courses that allow undergraduates to work with human stem cells hands-on, according to Chuck Toth ...

(“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer ...

Teknova & Pluristyx introduce proprietary PluriFreeze cryopreservation system to accelerate the development of cell therapies: Hollister, California Friday, March 21, 2025, 13:00 ...

Inherited retinal dystrophies (IRDs), including retinitis pigmentosa and Stargardt disease, are a group of rare degenerative disorders of the retina with clinical and genetic heterogeneity. In a ...